13,14-Dihydro-15-keto-PGE2
13,14-Dihydro-15-keto-PGE2 participates in Bifidobacterium animalis F1-7 to alleviate opioid-induced constipation by 5-HT pathway[1].
Product Specifications
CAS Number
[363-23-5]
UNSPSC
12352211
Hazard Statement
H302, H315, H319, H335
Target
5-HT Receptor; Endogenous Metabolite
Type
Reference compound
Related Pathways
GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/13-14-dihydro-15-keto-pge2.html
Concentration
28.37 mM * 100 μL in Methyl acetate
Purity
96.7
Smiles
CCCCCC(CC[C@@H]1[C@H](C(C[C@H]1O)=O)C/C=C\CCCC(O)=O)=O
Molecular Formula
C20H32O5
Molecular Weight
352.47
Precautions
H302, H315, H319, H335
References & Citations
[1]Youyou Lu, et al. Metabolites 13,14-Dihydro-15-keto-PGE2 Participates in Bifidobacterium animalis F1-7 to Alleviate Opioid-Induced Constipation by 5-HT Pathway. Mol Nutr Food Res. 2024 Feb;68 (3) :e2200846.
Shipping Conditions
Blue Ice
Storage Conditions
Solution, -20°C, 2 years
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
